ADM Announces Sale of Stake in GrainCorp
Get Alerts ADM Hot Sheet
Overall Analyst Rating:
NEUTRAL ( Up)
Dividend Yield: 3.8%
Revenue Growth %: -7.4%
Join SI Premium – FREE
CHICAGO--(BUSINESS WIRE)-- Archer Daniels Midland Company (NYSE: ADM) announced today that it has entered into an underwriting agreement to sell its 19.9 percent ownership stake in GrainCorp Limited (ASX: GNC) for a total value of about A$387 million.
“As part of our ongoing portfolio management, we carefully considered our equity investment position in GrainCorp and determined that we could better meet our long-term returns objectives by reallocating that capital,” said ADM Chairman and CEO Juan Luciano. “This transaction will allow us to further reduce our invested capital, and it will provide cash that we can redeploy to higher-return investments as we continue to execute our balanced capital-allocation framework.”
The transaction has been executed by way of an underwritten sale to an underwriter. Under the terms of the agreement, ADM will sell all of its 19.9 percent investment in the issued capital in GrainCorp at a price of A$8.53 per share.
About ADM
For more than a century, the people of Archer Daniels Midland Company (NYSE: ADM) have transformed crops into products that serve the vital needs of a growing world. Today, we’re one of the world’s largest agricultural processors and food ingredient providers, with more than 32,300 employees serving customers in more than 160 countries. With a global value chain that includes 428 crop procurement locations, 280 ingredient manufacturing facilities, 39 innovation centers and the world’s premier crop transportation network, we connect the harvest to the home, making products for food, animal feed, industrial and energy uses. Learn more at www.adm.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20161201006403/en/
Archer Daniels Midland Company
Media Relations
Jackie
Anderson
312-634-8484
[email protected]
Source: Archer Daniels Midland Company
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CARRIEVERSE Grand Open, Spearheading the Global Web3 Market.
- InnoCare Announces Dosing of First Patient in Clinical Study of the Combination of SHP2 Inhibitor ICP-189 and EGFR Inhibitor Furmonertinib
- Music China Returns in 2024 with Enhanced Quality Boosted by UFI Certification
Create E-mail Alert Related Categories
Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!